Krukenberg Progression of Gastric Carcinoma in Pregnancy: Is Early Diagnosis Possible? Case Report and Review of the Literature

by Fanny Eckel, Greta Carlin, Stefanie Mayer, Stephan Polterauer, Kinga Chalubinski
Published 2023-08-01

Isolated Short Fetal Femur Length in the Second Trimester and the Association with Adverse Perinatal Outcome: Experiences from a Tertiary Referral Center.

by Mariella Mailath-Pokorny, Stephan Polterauer, Katharina Worda, Stephanie Springer, Dieter Bettelheim
Published 2015-01-01

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.

by Veronika Seebacher, Alexander Reinthaller, Heinz Koelbl, Nicole Concin, Regina Nehoda, Stephan Polterauer
Published 2017-01-01

Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience

by Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm, Eva Langthaler, Stephan Polterauer
Published 2024-06-01

Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters

by Elisabeth Reiser, Dietmar Pils, Christoph Grimm, Ines Hoffmann, Stephan Polterauer, Marlene Kranawetter, Stefanie Aust
Published 2022-06-01

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study

by Veronika Seebacher, Stephan Polterauer, Alexander Reinthaller, Heinz Koelbl, Regina Achleitner, Astrid Berger, Nicole Concin
Published 2018-04-01

Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer.

by Christine Staudigl, Nicole Concin, Christoph Grimm, Georg Pfeiler, Regina Nehoda, Christian F Singer, Stephan Polterauer
Published 2015-01-01

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach

by Christine Bekos, Besnik Muqaku, Sabine Dekan, Reinhard Horvat, Stephan Polterauer, Christopher Gerner, Stefanie Aust, Dietmar Pils
Published 2019-05-01

The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer

by Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
Published 2022-11-01

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer

by Christine Bekos, Christoph Grimm, Marlene Kranawetter, Stephan Polterauer, Felicitas Oberndorfer, Yen Tan, Leonhard Müllauer, Christian F. Singer
Published 2021-06-01

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival

by Myriam Gracia, Yusuf Yildirim, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Stephan Polterauer, Sara Iacoponi, Ignacio Zapardiel
Published 2023-02-01

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients

by Christina T. Grech, Dietmar Pils, Stefanie Aust, Christoph Grimm, Stephan Polterauer, Alexander Reinthaller, Leonhard Müllauer, Theresa Reischer, Christine Bekos
Published 2022-09-01

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients

by Thomas Bartl, Arina Onoprienko, Gerda Hofstetter, Leonhard Müllauer, Nina Poetsch, Thorsten Fuereder, Paul Kofler, Stephan Polterauer, Christoph Grimm
Published 2021-11-01

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome

by Christine Bekos, Dietmar Pils, Sabine Dekan, Gerda Hofstetter, Peter Horak, Alexander Reinthaller, Stephan Polterauer, Richard Schwameis, Stefanie Aust
Published 2021-03-01

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer.

by Stefanie Aust, Thomas Knogler, Dietmar Pils, Eva Obermayr, Alexander Reinthaller, Lisa Zahn, Ilja Radlgruber, Marius Erik Mayerhoefer, Christoph Grimm, Stephan Polterauer
Published 2015-01-01

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

by Felicitas Oberndorfer, Sarah Moling, Leonie Annika Hagelkruys, Christoph Grimm, Stephan Polterauer, Alina Sturdza, Stefanie Aust, Alexander Reinthaller, Leonhard Müllauer, Richard Schwameis
Published 2021-01-01

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.

by Richard Schwameis, Christoph Grimm, Edgar Petru, Camilla Natter, Christine Staudigl, Wolfgang Lamm, Heinz Koelbl, Michael Krainer, Thomas Brodowicz, Alexander Reinthaller, Stephan Polterauer
Published 2015-01-01

Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.

by Veronika Seebacher, Stefanie Aust, David D'Andrea, Christoph Grimm, Elisabeth Reiser, Denise Tiringer, Hannah Von Mersi, Stephan Polterauer, Alexander Reinthaller, Samir Helmy-Bader
Published 2017-01-01

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer

by Stefanie Aust, Richard Schwameis, Tamara Gagic, Leonhard Müllauer, Eva Langthaler, Gerald Prager, Christina Grech, Alexander Reinthaller, Michael Krainer, Dietmar Pils, Christoph Grimm, Stephan Polterauer
Published 2020-02-01

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients

by Christian F. Singer, Yen Y. Tan, Daniela Muhr, Christine Rappaport, Daphne Gschwantler‐Kaulich, Christoph Grimm, Stephan Polterauer, Georg Pfeiler, Andreas Berger, Muy‐Kheng M. Tea
Published 2019-04-01